Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration

Stem Cells and Development

Volumn 21, Issue 2, 2012, Pages 228-238

  Maijenburg, Marijke W ^a   Gilissen, Christian ^b   Melief, Sara M ^c   Kleijer, Marion ^a   Weijer, Kees ^a   Ten Brinke, Anja ^a   Roelofs, Helene ^c   Van Tiel, Claudia M ^a   Veltman, Joris A ^b   De Vries, Carlie J M ^a   Van Der Schoot, C Ellen ^a   Voermans, Carlijn ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LENTIVIRUS VECTOR; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FETUS; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMA CELL; MIXED LYMPHOCYTE REACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

BONE MARROW; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LENTIVIRUS; MESENCHYMAL STROMAL CELLS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PROTO-ONCOGENE PROTEINS C-SIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION;

EID: 84855840769     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0076     Document Type: Article

References (55)

1. Nauta AJ and WE Fibbe. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506. (Pubitemid 350159613)
2. da Silva ML, PC Chagastelles and NB Nardi. (2006). Me-senchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213. (Pubitemid 43960310)
3. Fan CG, FW Tang, QJ Zhang, SH Lu, HY Liu, ZM Zhao, B Liu, ZB Han and ZC Han. (2005). Characterization and neural differentiation of fetal lung mesenchymal stem cells. Cell Transplant 14:311-321. (Pubitemid 41022836)
4. In't Anker PS, WA Noort, SA Scherjon, C Kleijburg-van der Keur, AB Kruisselbrink, RL van Bezooijen, W Beekhuizen, R Willemze, HH Kanhai and WE Fibbe (2003) Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Hae-matologica 88:845-852. (Pubitemid 37128084)
5. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
6. Horwitz EM, DJ Prockop, LA Fitzpatrick, WW Koo, PL Gordon, M Neel, M Sussman, P Orchard, JC Marx, RE Pyeritz and MK Brenner. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309-313. (Pubitemid 29124367)
7. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploi-dentical mesenchymal stem cells. Lancet 363:1439-1441. (Pubitemid 38586721)
8. Rombouts WJ and RE Ploemacher. (2003). Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17:160-170. (Pubitemid 36175902)
9. Francois S, M Bensidhoum, M Mouiseddine, C Mazurier, B Allenet, A Semont, J Frick, A Sache, S Bouchet, et al. (2006). Local irradiation not only induces homing of human mes-enchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24:1020-1029. (Pubitemid 44464735)
10. Lee RH, AA Pulin, MJ Seo, DJ Kota, J Ylostalo, BL Larson, L Semprun-Prieto, P Delafontaine and DJ Prockop. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63.
11. Bhakta S, P Hong and O Koc. (2006). The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med 7:19-24.
12. Son BR, LA Marquez-Curtis, M Kucia, M Wysoczynski, AR Turner,JRatajczak,MZRatajczak andAJanowska-Wieczorek. (2006). Migration of bone marrow and cord blood mesenchy-mal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264. (Pubitemid 44464694)
13. Fiedler J, N Etzel and RE Brenner. (2004). To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990-998. (Pubitemid 44264152)
14. Forte G, M Minieri, P Cossa, D Antenucci, M Sala, V Gnocchi, R Fiaccavento, F Carotenuto, P De Vito, et al. (2006). Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells 24:23-33.
15. Schmidt A, D Ladage, T Schinkothe, U Klausmann, C Ulrichs, FJ Klinz, K Brixius, S Arnhold, B Desai, et al. (2006). Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24:1750-1758. (Pubitemid 44474188)
16. Maijenburg MW, WA Noort, M Kleijer, CJ Kompier, K Weijer, JD van Buul, CE van der Schoot and C Voermans. (2010). Cell cycle and tissue of origin contribute to the migratory behaviour of human fetal and adult mesenchymal stromal cells. Br J Haematol 148:428-440.
17. Ozaki Y, M Nishimura, K Sekiya, F Suehiro, M Kanawa, H Nikawa, T Hamada and Y Kato. (2007). Comprehensive analysis of chemotactic factors for bone marrow mesenchy-mal stem cells. Stem Cells Dev 16:119-129. (Pubitemid 46362597)
18. Sengenes C, A Miranville, M Maumus, S De Barros, R Busse and A Bouloumie. (2007). Chemotaxis and differentiation of human adipose tissue CD34+/CD31- progenitor cells: role of stromal derived factor-1 released by adipose tissue capillary endothelial cells. Stem Cells 25:2269-2276. (Pubitemid 47480485)
19. Schmidt A, D Ladage, C Steingen, K Brixius, T Schinkothe, FJ Klinz, RH Schwinger, U Mehlhorn and W Bloch. (2006). Mesenchymal stem cells transmigrate over the endothelial barrier. Eur J Cell Biol 85:1179-1188. (Pubitemid 44524624)
20. Ponte AL, E Marais, N Gallay, A Langonne, B Delorme, O Herault, P Charbord and J Domenech. (2007). The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737-1745. (Pubitemid 47121852)
21. Glimm H, IH Oh and CJ Eaves. (2000). Human hematopoi-etic stem cells stimulated to proliferate in vitro lose engraft-ment potential during their S/G(2)/M transit and do not reenter G(0). Blood 96:4185-4193.
22. Noort WA, AB Kruisselbrink, PS in't Anker, M Kruger, RL van Bezooijen, RA de Paus, MH Heemskerk, CW Lowik, JH Falkenburg, R Willemze and WE Fibbe. (2002). Mesenchy-mal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 30:870-878. (Pubitemid 34838889)
23. Bonta PI, CM van Tiel, M Vos, TW Pols, JV van Thienen, V Ferreira, EK Arkenbout, J Seppen, CA Spek, et al. (2006). Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler Thromb Vasc Biol 26:2288-2294. (Pubitemid 44465724)
24. Sastry L, T Johnson, MJ Hobson, B Smucker and K Cornetta. (2002). Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 9:1155-1162. (Pubitemid 34993938)
25. Pols TW, PI Bonta and CJ de Vries. (2007). NR4A nuclear orphan receptors: protective in vascular disease? Curr Opin Lipidol 18:515-520. (Pubitemid 47462203)
26. Zhao Y and D Bruemmer. (2010). NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol 30:1535-1541.
27. Nomiyama T, T Nakamachi, F Gizard, EB Heywood, KL Jones, N Ohkura, R Kawamori, OM Conneely and D Bruemmer. (2006). The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J Biol Chem 281:33467-33476. (Pubitemid 46036728)
28. Zhao D, S Desai and H Zeng. (2010). VEGF stimulates orphan nuclear receptor nurr1 expression via PKC-dependent PKD-mediated CREB activation in endothelial cells. Int J Cancer 128:2602-2612.
29. Pei L, A Castrillo, M Chen, A Hoffmann and P Tontonoz. (2005). Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 280:29256-29262. (Pubitemid 41161379)
30. Fiedler J, G Roderer, KP Gunther and RE Brenner. (2002). BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87:305-312. (Pubitemid 35231716)
31. Winoto A and DR Littman. (2002). Nuclear hormone receptors in T lymphocytes. Cell 109 Suppl:S57-S66. (Pubitemid 34457852)
32. Lin B, SK Kolluri, F Lin, W Liu, YH Han, X Cao, MI Dawson, JC Reed and XK Zhang. (2004). Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116:527-540. (Pubitemid 38264430)
33. Kim SO, K Ono, PS Tobias and J Han. (2003). Orphan nuclear receptor Nur77 is involved in caspase-independent macrophage cell death. J Exp Med 197:1441-1452. (Pubitemid 36682543)
34. Arkenbout EK, M van Bragt, E Eldering, BC van, JM Grimbergen, PH Quax, H Pannekoek and CJ de Vries. (2003). TR3 orphan receptor is expressed in vascular endo-thelial cells and mediates cell cycle arrest. Arterioscler Thromb Vasc Biol 23:1535-1540. (Pubitemid 37108194)
35. Arkenbout EK, V de Waard, M van Bragt, TA van Achterberg, JM Grimbergen, B Pichon, H Pannekoek and CJ de Vries. (2002). Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 106:1530-1535.
36. de Waard V, EK Arkenbout, M Vos, AI Mocking, HW Niessen, W Stooker, BA de Mol, PH Quax, EN Bakker, et al. (2006). TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Pathol 168:2027-2035. (Pubitemid 43825321)
37. Wagner W, C Roderburg, F Wein, A Diehlmann, M Fran-khauser, R Schubert, V Eckstein and AD Ho. (2007). Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 25:2638-2647. (Pubitemid 47582757)
38. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843. (Pubitemid 34534559)
39. Rasmusson I, O Ringden, B Sundberg and BK Le. (2003). Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76:1208-1213. (Pubitemid 37339646)
40. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736.
41. Meisel R, A Zibert, M Laryea, U Gobel, W Daubener and D Dilloo. (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621. (Pubitemid 38745993)
42. Krampera M, L Cosmi, R Angeli, A Pasini, F Liotta, A Andreini, V Santarlasci, B Mazzinghi, G Pizzolo, et al. (2006). Role for interferon-gamma in the immunomodula-tory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398. (Pubitemid 44464808)
43. Lee RH, MJ Seo, AA Pulin, CA Gregory, J Ylostalo and DJ Prockop. (2009). The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood 113:816-826.
44. Stich S, M Haag, T Haupl, O Sezer, M Notter, C Kaps, M Sittinger and J Ringe. (2009). Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res 336:225-236.
45. Kalwitz G, M Endres, K Neumann, K Skriner, J Ringe, O Sezer, M Sittinger, T Haupl and C Kaps. (2009). Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int J Biochem Cell Biol 41:649-658.
46. Wallen A, RH Zetterstrom, L Solomin, M Arvidsson, L Olson and T Perlmann. (1999). Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp Cell Res 253:737-746. (Pubitemid 30003136)
47. Inamoto T, BA Czerniak, CP Dinney and AM Kamat. (2010). Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer 116:340-346.
48. Ramaswamy S, KN Ross, ES Lander and TR Golub. (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54. (Pubitemid 36068681)
49. Sirin O, GL Lukov, R Mao, OM Conneely and MA Goodell. (2010). The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells. Nat Cell Biol 12:1213-1219.
50. Aherne CM, J McMorrow, D Kane, O FitzGerald, KS Mix and EP Murphy. (2009). Identification of NR4A2 as a tran-scriptional activator of IL-8 expression in human inflammatory arthritis. Mol Immunol 46:3345-3357.
51. Saijo K, B Winner, CT Carson, JG Collier, L Boyer, MG Rosenfeld, FH Gage and CK Glass. (2009). A Nurr1/CoR-EST pathway in microglia and astrocytes protects dopami-nergic neurons from inflammation-induced death. Cell 137:47-59.
52. Pei L, A Castrillo and P Tontonoz. (2006). Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol 20:786-794.
53. Jones SA. (2005). Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175:3463-3468. (Pubitemid 41292002)
54. Nauta AJ, AB Kruisselbrink, E Lurvink, R Willemze and WE Fibbe. (2006). Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177:2080-2087. (Pubitemid 44200965)
55. Baggiolini M. (1993). Novel aspects of inflammation: interleu-kin-8 and related chemotactic cytokines. Clin Invest 71:812-814. (Pubitemid 23303024)